Go to content

Health Canada approves third and fourth COVID-19 vaccines

Health Canada approves third and fourth COVID-19 vaccines
/ Yulia Reznikov / Moment / Getty Images

Health Canada has approved two new COVID-19 vaccines. On Friday morning, the federal health agency announced the approval of the AstraZeneca vaccine and the Serum Institute of India vaccine, India’s version of the AstraZeneca vaccine.

Canada has pre-ordered 20 million doses of the AstraZeneca vaccine, which was co-developed by researchers at the University of Oxford and will receive an additional 1.9 million doses of the AstraZeneca vaccine through the global vaccine-sharing initiative known as COVAX by the end of June.

The vaccines are authorized for use in people over 18 years of age and are administered as a two-dose regimen. Doses of the AstraZeneca shot can be stored at temperatures between 2 C to 8 C, while the other two require ultra-cold freezers much like the Pfizer vaccine.

Approval of the much talked about Johnson and Johnson’s vaccine will likely not come until early March and the Novavax vaccine is not expected until April, the earliest.

Health Canada says the vaccine is 62% effective at preventing cases of COVID-19, overall.

Approximately 1.7 million doses of those formulas have been administered in Canada.

For more information, we recommend reading this very detailed report from the Montreal Gazette

Subscribe to our newletter!Subscribe to our newletter!
By subscribing, I agree to receive communications by email from Cogeco Média and its affiliates, including news, updates, activities and contests. You can unsubscribe at any time by using the link at the bottom of our emails or contacting us via our Privacy Policy. Please note, however, that we may still continue to send you service-related and other non-commercial communications. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Streaming will resume following advertisement.
The Beat of your Workday with Donna